Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan

Director William Hoffman sold shares of Inari Medical (NARI) on June 17, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• William Hoffman, a director of Inari Medical, Inc. (NARI), sold shares of common stock on June 17, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• A total of 40,000 shares were sold in multiple transactions at varying prices.
• The weighted average sale prices ranged from $43.31 to $45.85.
• Following the reported transactions, Hoffman beneficially owns 825,359 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned, as in this case with the 10b5-1 trading plan. The market typically analyzes these sales in the context of the company's overall performance and future prospects.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates